473 related articles for article (PubMed ID: 16206505)
1. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
[TBL] [Abstract][Full Text] [Related]
2. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?
Charlton M
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):72-3. PubMed ID: 16456570
[No Abstract] [Full Text] [Related]
3. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis.
Hidaka H; Nakazawa T; Kutsukake S; Yamazaki Y; Aoki I; Nakano S; Asaba N; Minamino T; Takada J; Tanaka Y; Okuwaki Y; Watanabe M; Shibuya A; Koizumi W
J Gastroenterol; 2013 Feb; 48(2):269-76. PubMed ID: 22825550
[TBL] [Abstract][Full Text] [Related]
5. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.
Habu D; Nishiguchi S; Nakatani S; Lee C; Enomoto M; Tamori A; Takeda T; Ohfuji S; Fukushima W; Tanaka T; Kawamura E; Shiomi S
Hepatogastroenterology; 2009; 56(96):1719-23. PubMed ID: 20214224
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus.
Kobayashi M; Ikeda K; Arase Y; Suzuki Y; Suzuki F; Akuta N; Hosaka T; Murashima N; Saitoh S; Someya T; Tsubota A; Kumada H
J Gastroenterol; 2008; 43(1):63-70. PubMed ID: 18297438
[TBL] [Abstract][Full Text] [Related]
8. Early administration of branched-chain amino acid granules.
Ishikawa T
World J Gastroenterol; 2012 Sep; 18(33):4486-90. PubMed ID: 22969221
[TBL] [Abstract][Full Text] [Related]
9. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.
Marchesini G; Bianchi G; Merli M; Amodio P; Panella C; Loguercio C; Rossi Fanelli F; Abbiati R;
Gastroenterology; 2003 Jun; 124(7):1792-801. PubMed ID: 12806613
[TBL] [Abstract][Full Text] [Related]
10. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
[TBL] [Abstract][Full Text] [Related]
11. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.
Yoshida T; Muto Y; Moriwaki H; Yamato M
Gastroenterol Jpn; 1989 Dec; 24(6):692-8. PubMed ID: 2606303
[TBL] [Abstract][Full Text] [Related]
13. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
[TBL] [Abstract][Full Text] [Related]
14. Impact of Branched-Chain Amino Acid-Enriched Nutrient on liver Cirrhosis with Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization in Barcelona Clinic Liver Cancer Stage B: A Prospective Study.
Shiozawa S; Usui T; Kuhara K; Tsuchiya A; Miyauchi T; Kono T; Asaka S; Yamaguchi K; Yokomizo H; Shimakawa T; Yoshimatsu K; Katsube T; Naritaka Y
J Nippon Med Sch; 2016; 83(6):248-256. PubMed ID: 28133005
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis.
Moriwaki H; Shiraki M; Fukushima H; Shimizu M; Iwasa J; Naiki T; Nagaki M
Hepatol Res; 2008 Nov; 38 Suppl 1():S102-6. PubMed ID: 19125940
[TBL] [Abstract][Full Text] [Related]
16. Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis.
Miyake T; Abe M; Furukawa S; Tokumoto Y; Toshimitsu K; Ueda T; Yamamoto S; Hirooka M; Kumagi T; Hiasa Y; Matsuura B; Onji M
Intern Med; 2012; 51(16):2151-5. PubMed ID: 22892494
[TBL] [Abstract][Full Text] [Related]
17. Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.
Sakai Y; Iwata Y; Enomoto H; Saito M; Yoh K; Ishii A; Takashima T; Aizawa N; Ikeda N; Tanaka H; Iijima H; Nishiguchi S
J Gastroenterol; 2015 Jan; 50(1):109-18. PubMed ID: 24633624
[TBL] [Abstract][Full Text] [Related]
18. [Branched chain amino acids as oral supplements in liver cirrhosis].
Plauth M
Z Gastroenterol; 2006 Feb; 44(2):207-8. PubMed ID: 16456764
[No Abstract] [Full Text] [Related]
19. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration.
Fukushima H; Miwa Y; Ida E; Kuriyama S; Toda K; Shimomura Y; Sugiyama A; Sugihara J; Tomita E; Moriwaki H
JPEN J Parenter Enteral Nutr; 2003; 27(5):315-22. PubMed ID: 12971730
[TBL] [Abstract][Full Text] [Related]
20. [Protein catabolism and malnutrition in liver cirrhosis - impact of oral nutritional therapy].
Norman K; Valentini L; Lochs H; Pirlich M
Z Gastroenterol; 2010 Jul; 48(7):763-70. PubMed ID: 20607635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
